Treatment with IL-4 and -13 stimulates MUC5AC and MUC5B secretion in patients with CRSwNP via IL-4α, which is also highly expressed in patients with IL-5(+) CRSwNP [84]. The gene discussed is IL5; the disease is chronic rhinosinusitis with nasal polyps.